5. All endpoints in comparison 2.
Endpoint | No. events/patients | HR (95% CI), p | Heterogeneity p |
Survival | 368/872 | 0.65 (0.53‐0.80), 0.00004 | 0.06 |
Disease‐free survival | 414/872 | 0.68 (0.56‐0.82), 0.0001 | 0.02 |
Loco‐regional disease‐free survival | 402/872 | 0.68 (0.56‐0.82), 0.0001 | 0.005 |
Metastases‐free survival | 381/872 | 0.63 (0.52‐0.78), 0.00001 | 0.217 |